NIH-funded research R01 grant

A new method for delivering biomolecules directly into cells

Official title: Guided Intracellular Delivery using Precise Area Introduction and Transfection (PAINT)

Funded at Georgia Institute of Technology · NIH-10938834 · Data updated 2026-11-12

This study is testing a new method called PAINT that helps deliver important molecules like DNA or proteins directly into specific cells, which could lead to better treatments for patients needing precise cellular therapies.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionGeorgia Institute of Technology
NIH-funded
Lab location1 site (Atlanta, United States)
Project startSeptember 25, 2024
Project endJuly 31, 2028
Funding year2024
Award (this year)$488,753
NIH project number1R01GM154933-01
Project IDNIH-10938834 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research would include individuals with conditions that could benefit from targeted cellular therapies, such as genetic disorders or cancers.

Less likely to help

Patients who do not have conditions requiring cellular modification or those who are not candidates for biomolecule therapies may not benefit from this research.

What this research studies

This research focuses on developing a technique called PAINT (Precise Area Introduction and Transfection) that allows for the targeted delivery of biomolecules into specific cells. By using a specialized device, researchers aim to precisely control how and where these biomolecules, such as DNA or proteins, are introduced into cells. This method seeks to overcome the limitations of current delivery techniques, which often lack precision and versatility. Patients may benefit from advancements in therapies that rely on effective cellular modification.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatments for various diseases by improving how therapies are delivered at the cellular level.

How similar studies have gone: While the approach of precise biomolecule delivery is innovative, similar techniques have shown promise in preliminary studies, indicating potential for success.

Where this research is happening

  • Georgia Institute of Technology
    Atlanta, United States
    Active

Researchers

  • Principal investigator: Fedorov, Andrei G — Georgia Institute of Technology
  • Study coordinator: Fedorov, Andrei G

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.